Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
New Poteintial Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies.
Mir-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Kinetic Characterization of Ebselen, Chelerythrine and Apomorphine as Glutaminase Inhibitors.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Evolution of tumefactive lesions in multiple sclerosis: A 12-year study with serial imaging in a single patient.
Differential diagnoses to MS: experiences from an optic neuritis clinic.
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Growth Hormone and Disease Severity in Early Stage of Multiple Sclerosis.
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Neuroinflammation: no rose by any other name.
Serum proteomics in multiple sclerosis disease progression.
Neurotoxocarosis alters myelin protein gene transcription and expression.
Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Neurology of inherited glycosylation disorders.
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
Human endogenous retrovirus-K contributes to motor neuron disease.
Pages
« first
‹ previous
…
555
556
557
558
559
560
561
562
563
…
next ›
last »